Adam DuVall

604 total citations
44 papers, 244 citations indexed

About

Adam DuVall is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Oncology. According to data from OpenAlex, Adam DuVall has authored 44 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 17 papers in Hematology and 14 papers in Oncology. Recurrent topics in Adam DuVall's work include Acute Lymphoblastic Leukemia research (19 papers), Acute Myeloid Leukemia Research (13 papers) and Childhood Cancer Survivors' Quality of Life (13 papers). Adam DuVall is often cited by papers focused on Acute Lymphoblastic Leukemia research (19 papers), Acute Myeloid Leukemia Research (13 papers) and Childhood Cancer Survivors' Quality of Life (13 papers). Adam DuVall collaborates with scholars based in United States, United Kingdom and France. Adam DuVall's co-authors include Anao Zhang, Eric M. Muchiri, Jessica K. Fairley, Anand Patel, Amaya L. Bustinduy, Laura J. Sutherland, Uriel Kitron, Charles H. King, Emily Walling and Peter Mungai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Adam DuVall

39 papers receiving 240 citations

Peers

Countries citing papers authored by Adam DuVall

Since Specialization

Citations

This map shows the geographic impact of Adam DuVall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam DuVall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam DuVall more than expected).

Fields of papers citing papers by Adam DuVall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam DuVall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam DuVall. The network helps show where Adam DuVall may publish in the future.

Co-authorship network of co-authors of Adam DuVall

This figure shows the co-authorship network connecting the top 25 collaborators of Adam DuVall. A scholar is included among the top collaborators of Adam DuVall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam DuVall. Adam DuVall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination 2025 ·JNCI Journal of the National Cancer Institute ·Katie A. Greenzang, Kathleen Montgomery, Adam DuVall, Michael Roth, (unknown), (unknown), Lindsay A. Renfro, (unknown), John J. Doski, Kara M. Kelly, Sharon M. Castellino, Jennifer L. McNeer, Maureen M. O’Brien, Damon R. Reed, Katherine A. Janeway, Pamela S. Hinds, Sue Zupanec, Susan K. Parsons	0
2	The ethics of climate change and health-care delivery: a national survey of US-based physicians 2025 ·The Lancet Planetary Health ·Andrew Hantel, Emily Senay, Fay J. Hlubocky, Thomas Walsh, (unknown), Angel M. Cronin, Adam DuVall, Anna Revette, (unknown), Mark Siegler, Cristina Richie, Gregory A. Abel	0
3	Expedited evaluation of hereditary hematopoietic malignancies in the setting of stem cell transplantation 2024 ·Haematologica ·Gregory W. Roloff, Satyajit Kosuri, (unknown), Adam DuVall, Anand Patel, Peter A. Riedell, Olatoyosi Odenike, Wendy Stock, Richard A. Larson, Michael R. Bishop, (unknown), Lucy A. Godley, (unknown), Daniela del Gaudio, Soma Das, (unknown), Michael W. Drazer	1
4	Treating Mental Health and Quality of Life in Older Cancer Patients with Cognitive Behavioral Therapy: A Systematic Review and Meta-Analysis 2024 ·International Journal of Environmental Research and Public Health ·Kathryn O’Keefe, (unknown), (unknown), Adam DuVall, (unknown)	5
5	Interim Results of a Phase II Study Investigating Dasatinib and Inotuzumab Ozogamicin-Based Induction for Newly-Diagnosed Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) 2024 ·Blood ·Anand Patel, Adam DuVall, Caner Saygin, Howard Weiner, (unknown), (unknown), (unknown), (unknown), Michael W. Drazer, (unknown), Gregory W. Roloff, Satyajit Kosuri, Michael J. Thirman, Richard A. Larson, Olatoyosi Odenike, Theodore Karrison, Wendy Stock	2
6	Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia 2023 ·Clinical Cancer Research ·Caner Saygin, (unknown), (unknown), (unknown), (unknown), Girish Venkataraman, Vijayalakshmi Ananthanarayanan, Tiffaney L. Vincent, Adam DuVall, Anand Patel, (unknown), Fenlai Tan, Stephen P. Anthony, (unknown), Yue Shen, Olatoyosi Odenike, David T. Teachey, Barbara L. Kee, James L. LaBelle, Wendy Stock	10
7	Tailoring Solution-Focused Brief Therapy for Adolescents and Young Adults with Cancer: A Qualitative Investigation 2023 ·Clinical Social Work Journal ·Anao Zhang, Adam DuVall, Cynthia Franklin, Johnny S. Kim	1
8	Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND) 2023 ·Leukemia ·Talha Badar, Ehab Atallah, Rory M. Shallis, Antoine N. Saliba, Anand Patel, Jan Philipp Bewersdorf, (unknown), Maximilian Stahl, Adam DuVall, Madelyn Burkart, Neil Palmisiano, (unknown), Michal Kubiak, Shira Dinner, Aaron D. Goldberg, Yasmin Abaza, Guru Subramanian Guru Murthy, Vamsi Kota, Mark R. Litzow	29
9	Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis 2023 ·Clinical Therapeutics ·(unknown), Chaoling Feng, Christine Fu, Chong Kim, James J. Wu, David Dalton, (unknown), Julia Thornton Snider, Adam DuVall	1
10	Gaps in Adolescent and Young Adult Cancer Education in Oncology Fellowship Training 2023 ·Journal of Adolescent and Young Adult Oncology ·(unknown), Adam DuVall, Brandon Hayes‐Lattin, (unknown), Pinki Prasad, John C. Molina, Varun Monga, David R. Freyer, Michael Roth	6
11	Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors 2023 ·British Journal of Haematology ·(unknown), Adam DuVall, Caner Saygin, Peng Wang, Sandeep Gurbuxani, Richard A. Larson, Wendy Stock, Anand Patel	3
12	Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma 2023 ·Current Hematologic Malignancy Reports ·Adam DuVall, (unknown), Richard A. Larson	2
13	Disparities in care and outcomes for adolescent and young adult lymphoma patients 2023 ·SHILAP Revista de lepidopterología ·Allison Rosenthal, Adam DuVall, Justine M. Kahn, Niloufer Khan	4
14	Validation and clinical application of transactivation assays forRUNX1variant classification 2022 ·Blood Advances ·(unknown), Anupriya Agarwal, (unknown), Jane E. Churpek, Nicolas Duployez, Adam DuVall, (unknown), (unknown), Hildegunn Høberg‐Vetti, Inga Hofmann, Michelle M. Nash, Marc H.G.P. Raaijmakers, Tor Henrik Anderson Tvedt, Adrianna Vlachos, Brigitte Schlegelberger, Thomas Illig, Tim Ripperger	4
15	Disparities in receiving disease‐directed therapy, allogeneic stem cell transplantation in non‐Hispanic Black patients with TP53‐mutated acute myeloid leukemia 2022 ·Cancer ·Talha Badar, Mark R. Litzow, Rory M. Shallis, Anand Patel, Antoine N. Saliba, Madelyn Burkart, Jan Philipp Bewersdorf, Maximilian Stahl, (unknown), Guru Subramanian Guru Murthy, Yasmin Abaza, Adam DuVall, (unknown), Vamsi Kota, Shira Dinner, Aaron D. Goldberg, Neil Palmisiano, (unknown), Ehab Atallah	5
16	Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents 2022 ·Journal of Assisted Reproduction and Genetics ·(unknown), Adam DuVall, Wendy Stock, (unknown)	4
17	Effectiveness of cognitive behavioral therapy in improving functional health in cancer survivors: A systematic review and meta-analysis 2022 ·Critical Reviews in Oncology/Hematology ·(unknown), (unknown), (unknown), (unknown), Emily Walling, Adam DuVall, Anao Zhang	21
18	Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation 2017 ·Bone Marrow Transplantation ·David N. O’Dwyer, Adam DuVall, Meng Xia, (unknown), (unknown), (unknown), Xiaofeng Zhou, Susan Murray, Bethany B. Moore, Gregory A. Yanik	15
19	Age-Stratified Profiles of Serum IL-6, IL-10, and TNF-α Cytokines Among Kenyan Children with Schistosoma haematobium, Plasmodium falciparum, and Other Chronic Parasitic Co-Infections 2015 ·American Journal of Tropical Medicine and Hygiene ·Amaya L. Bustinduy, Laura J. Sutherland, (unknown), Indu Malhotra, Adam DuVall, Jessica K. Fairley, Peter Mungai, Eric M. Muchiri, Francis Mutuku, Uriel Kitron, Charles H. King	29
20	Development of a Specimen-Sparing Multichannel Bead Assay to Detect Antiparasite IgG4 for the Diagnosis of Schistosoma and Wuchereria Infections on the Coast of Kenya 2014 ·American Journal of Tropical Medicine and Hygiene ·Adam DuVall, Jessica K. Fairley, Laura J. Sutherland, Amaya L. Bustinduy, Peter Mungai, Eric M. Muchiri, (unknown), Uriel Kitron, Charles H. King	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact